Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 16NIH 13NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 2Thoracic 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Osteosarcoma 2Sarcoma 1

Interventions

Radiotherapy 35Doxorubicin 30Ifosfamide 29Cyclophosphamide 24Vincristine 23Filgrastim 23Etoposide 20Temozolomide 14Granulocyte Colony-Stimulating Factor 14Dactinomycin 11Cisplatin 11Trabectedin 10Methotrexate 10Gene Expression Profiling 10Radiation 9Imatinib Mesylate 9Surgical Procedures, Operative 8Polymerase Chain Reaction 8Irinotecan 8Specimen Handling 7Paclitaxel 7Chemotherapy, Adjuvant 7Mesna 6Immunohistochemistry 6Gemcitabine 6Carmustine 6Biopsy 6sargramostim 5pegfilgrastim 5etoposide phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Sorafenib × Sarcoma × Clear all
NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed
38 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT00889057 2013-03-28

Sorafenib in Relapsed High Grade Osteosarcoma

Italian Sarcoma Group

Phase 2 Completed
35 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡